Safety of using montelukast during pregnancy

Canadian Family Physician

Volumn 56, Issue 9, 2010, Pages 881-882

  Koren, Gideon ^a   Sarkar, Moumita ^a   Einarson, Adrienne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST;

ASTHMA; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DRUG EFFECT; DRUG SAFETY; FEMALE; FETUS DISTRESS; HUMAN; LIMB DEFECT; PREGNANCY; SHORT SURVEY; TREATMENT OUTCOME;

ABNORMALITIES, DRUG-INDUCED; ACETATES; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; PREGNANCY; PREGNANCY COMPLICATIONS; QUINOLINES;

EID: 77957662748     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Kwon HL, Triche EW, Belanger K, Bracken MB. The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 2006;26(1):29-62. (Pubitemid 43144610)
2. Frezzo T, McMahon CL, Pergament E. Asthma and pregnancy. IL Teratogen Inf Serv 2002;9(2):1-5.
3. Tamási L, Somoskövi A, Müller V, Bártfai Z, Acs N, Puhó E, et al. A population-based case-control study on the effect of bronchial asthma during pregnancy for congenital abnormalities of the offspring. J Asthma 2006;43(1):81-6. (Pubitemid 43916348)
4. Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006;61(2):169-76.
5. Källén B, Rydhstroem H, Aberg A. Asthma during pregnancy-a population based study. Eur J Epidemiol 2000;16(2):167-71.
6. Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol 1998;92(3):435-40.
7. Källén B, Otterbald Olausson P. Use of anti-asthmatic drugs during pregnancy. 2. Infant characteristics excluding congenital malformations. Eur J Clin Pharmacol 2007;63(4):375-81. Epub 2007 Jan 30. (Pubitemid 46399129)
8. Merck & Co. Merck Research Laboratories seventh annual report on exposure during pregnancy from the Merck Pregnancy Registry for SINGULAIR (montelukast sodium) covering the period from U.S. approval (February 20, 1998) through May 22, 2006. West Point, PA: Merck Research Labs; 2008. Available from: www.merckpregnancyregistries.com. Accessed 2010 Jun 25.
9. Gluck JC, Gluck PA. Asthma controller therapy during pregnancy. Am J Obstet Gynecol 2005;192(2):369-80.
10. American College of Obstetricians and Gynecologists, American College of Allergy, Asthma and Immunology. The use of newer asthma and allergy medications during pregnancy. Ann Allergy Asthma Immunol 2000;84(5):475-80.
11. Bakhireva LN, Jones KL, Schatz M, Klonoff-Cohen HS, Johnson D, Slymen DJ, et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol 2007;119(3):618-25. (Pubitemid 46320589)
12. Källén B, Otterbald Olausson P. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infant. Eur J Clin Pharmacol 2007;63(4):383-8. Epub 2007 Feb 6. (Pubitemid 46399130)
13. Sarkar M, Koren G, Ying A, Kalra S, Smorlesi C, De Santis M, et al. Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes. Eur J Clin Pharmacol. 2009 Aug 26. Epub ahead of print.